DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Herman AE, Chinn LW, Kotwal SG. , et al.
Safety, pharmacokinetics, and pharmacodynamics in healthy volunteers treated with GDC-0853, a selective reversible Bruton's tyrosine kinase inhibitor.
Clin Pharmacol Ther 2018;
103 (06) 1020-1028
We do not assume any responsibility for the contents of the web pages of other providers.